Risperidone

This classification denotes an antipsychotic agent with the molecular formula C23H27FN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6UH7ZF8HC, chemically known as 4h-pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl- but generally known as risperidone, which bears US NIH Compound Identifier 5073. European Medicines Agency schedules Risperidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10335MIG. The term RISPERIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules risperidone in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule risperidone under HS 29349990 and SITC 51579. As of Q4 2014, RISPERIDONE remains the US FDA Preferred Term for this commodity. Risperidone bears US NLM identifiers UMLS ID C0073393 and NCI Concept Code C29416. SMILES: FC1CC2ONC(C3CCN(CC3)CCC3C(=O)N4CCCCC4NC3C)C2CC1.